BACKGROUND AND PURPOSE: Systemic administration of cytosine-guanine (CpG) oligodeoxynucleotides provides neuroprotection against subsequent cerebral ischemic injury. We examined the genomic response of leukocytes and brain cells after ischemia in the context of CpG preconditioning. METHODS: RNA was isolated from circulating leukocytes and ischemic cortex 3 and 24 hours after middle cerebral artery occlusion after CpG or saline pretreatment and subjected to microarray analysis. Genes uniquely upregulated in CpG-pretreated mice were examined for overrepresented transcriptional regulatory elements. RESULTS: CpG preconditioning induced a novel response to middle cerebral artery occlusion within circulating leukocytes that was dominated by natural killer cell-associated genes and the GATA-3 transcriptional regulatory element. Preconditioning also caused a novel brain response to stroke that was dominated by Type I interferon, interferon-associated genes, and transcriptional regulatory elements. CONCLUSIONS: CpG preconditioning invokes novel leukocyte and brain responses to stroke. In this, CpG may be a unique preconditioning agent, coordinating peripheral and brain responses to protect against ischemic injury.
BACKGROUND AND PURPOSE: Systemic administration of cytosine-guanine (CpG) oligodeoxynucleotides provides neuroprotection against subsequent cerebral ischemic injury. We examined the genomic response of leukocytes and brain cells after ischemia in the context of CpG preconditioning. METHODS: RNA was isolated from circulating leukocytes and ischemic cortex 3 and 24 hours after middle cerebral artery occlusion after CpG or saline pretreatment and subjected to microarray analysis. Genes uniquely upregulated in CpG-pretreated mice were examined for overrepresented transcriptional regulatory elements. RESULTS: CpG preconditioning induced a novel response to middle cerebral artery occlusion within circulating leukocytes that was dominated by natural killer cell-associated genes and the GATA-3 transcriptional regulatory element. Preconditioning also caused a novel brain response to stroke that was dominated by Type I interferon, interferon-associated genes, and transcriptional regulatory elements. CONCLUSIONS: CpG preconditioning invokes novel leukocyte and brain responses to stroke. In this, CpG may be a unique preconditioning agent, coordinating peripheral and brain responses to protect against ischemic injury.
Authors: Lauren Rice; Daniel Orlow; Katherine Ceonzo; Gregory L Stahl; Aurthur O Tzianabos; Hiromi Wada; William C Aird; Jon A Buras Journal: J Infect Dis Date: 2005-03-03 Impact factor: 5.226
Authors: Wouter B Veldhuis; Sarah Floris; Peter H van der Meide; Ine M P Vos; Helga E de Vries; Christien D Dijkstra; Peter R Bär; Klaas Nicolay Journal: J Cereb Blood Flow Metab Date: 2003-09 Impact factor: 6.200
Authors: Wouter B Veldhuis; Joris W Derksen; Sarah Floris; Peter H Van Der Meide; Helga E De Vries; Janneke Schepers; Ine M P Vos; Christien D Dijkstra; L Jaap Kappelle; Klaas Nicolay; Peter R Bär Journal: J Cereb Blood Flow Metab Date: 2003-09 Impact factor: 6.200
Authors: Susan L Stevens; Thomas M P Ciesielski; Brenda J Marsh; Tao Yang; Delfina S Homen; Jo-Lynn Boule; Nikola S Lessov; Roger P Simon; Mary P Stenzel-Poore Journal: J Cereb Blood Flow Metab Date: 2008-01-09 Impact factor: 6.200
Authors: Mary P Stenzel-Poore; Susan L Stevens; Zhigang Xiong; Nikola S Lessov; Christina A Harrington; Motomi Mori; Robert Meller; Holly L Rosenzweig; Eric Tobar; Tatyana E Shaw; Xiangping Chu; Roger P Simon Journal: Lancet Date: 2003-09-27 Impact factor: 79.321
Authors: Frances Rena Bahjat; Rebecca L Williams-Karnesky; Steven G Kohama; G Alexander West; Kristian P Doyle; Maxwell D Spector; Theodore R Hobbs; Mary P Stenzel-Poore Journal: J Cereb Blood Flow Metab Date: 2011-02-02 Impact factor: 6.200
Authors: Susan L Stevens; Philberta Y Leung; Keri B Vartanian; Banu Gopalan; Tao Yang; Roger P Simon; Mary P Stenzel-Poore Journal: J Neurosci Date: 2011-06-08 Impact factor: 6.167